RCSI Medical University of Bahrain advocates for increased colorectal cancer awareness
Held in collaboration with the King Hamad University Hospital and the King Hamad American Mission Hospital, this campaign led by Professor Hussain Nasaif, Associate Professor in Nursing and Director of the MSc in Nursing Programme at RCSI Medical University of Bahrain, with the support of the Community Engagement Office, aimed at raising awareness about the early symptoms and risk factors of Colorectal Cancer.
As part of this initiative, over 250 individuals who visited both hospitals over the course of four days were demonstrated how CRC develops within the colon by our student volunteers using an inflatable colon model as an effective educational tool.
Colorectal – related to Colon and Rectum- Cancer (CRC) continues to pose a significant public health challenge in the Kingdom of Bahrain, with data highlighting the increase in new cases and the need for improved awareness, early detection and preventive measures.
According to the latest statistics from the World Health Organization's International Agency for Research on Cancer (IARC), Colorectal Cancer emerged in 2022 as the most commonly diagnosed cancer among men in the Kingdom of Bahrain, with an incidence rate of 14.8%. Among women, it is the second most common cancer, following breast cancer, with an incidence rate of 8.2%. When compared with figures from the wider West Asia region—9.7% among men and 8.7% among women—CRC appears more prevalent among Bahraini men, while the rate among women remains broadly similar.
Negative lifestyle factors, including smoking, alcohol consumption, obesity, a diet high in processed foods, fatty food, low fibre diet, and physical inactivity significantly contribute to the risk of developing Colorectal Cancer. Conversely, a balanced diet combined with regular physical activity can lower the risk and improve overall health outcomes.
Common symptoms of CRC include blood in the stool, incomplete bowel emptying, lower abdominal pain, unexplained weight loss, loss of appetite, fatigue and anaemia. Individuals experiencing these symptoms are advised to consult their family doctor to review their personal and family medical history and explore available CRC screening options. Regular CRC screening is recommended from the age of 45 for both men and women. Early detection dramatically increases the likelihood of successful treatment and patients' survival rate.
Professor Sameer Otoom, President of RCSI Medical University of Bahrain, commented: 'We are grateful to our partner hospitals for hosting and supporting our Colorectal Cancer awareness initiative. Our collaborative effort in engaging the public and extending the relevant healthcare services is critical in tackling this prevalent disease for the benefit of all people in the Kingdom of Bahrain. Such partnerships strengthen our mission to enhance community health through education, research, and service.'
RCSI Medical University of Bahrain remains committed to empowering the public with the knowledge and resources necessary to reduce the impact of Colorectal Cancer, as well as other prevalent diseases and health conditions. By fostering a culture of education, early detection, and prevention, we continue to play an active role in supporting the health and wellbeing of individuals and communities across the Kingdom of Bahrain.
About RCSI Medical University of Bahrain
RCSI Medical University of Bahrain is a constituent university of the Royal College of Surgeons in Ireland (RCSI), which was established in Dublin, Ireland, in 1784. RCSI Medical University of Bahrain, an independent private university, opened its doors to a cohort of 28 medical students in 2004. Today, the purpose-built campus is home to a student body of more than 1,600 across the Schools of Medicine; Nursing and Midwifery and Postgraduate Studies and Research. It is a not-for-profit health sciences institution focused on education and research to drive positive change in all areas of human health worldwide.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Khaleej Times
7 hours ago
- Khaleej Times
PureHealth reports Dh13.6 billion in revenue and Dh1.03 billion in net profit for H1
PureHealth Holding, the largest healthcare group in the Middle East, on Thursday announced a 9 per cent year-on-year revenue increase to Dh13.6 billion in H1 2025, driven by broad-based growth across both its healthcare and insurance verticals. Ebitda rose 8 per cent year-on-year to Dh2.3 billion in H1-2025, while net profit reached Dh1.03 billion, up 2 per cent year-on-year. As part of its continued evolution and transformation of acquired assets, PureHealth is streamlining its operating model built around two core verticals: Care and Cover. This structure brings together all Group businesses under each vertical, with 'Care' encompassing Hospitals, Procurement, Diagnostics, and Technology, while 'Cover' includes the Group's Insurance operations. Kamal Al Maazmi, Chairman of PureHealth, said: 'PureHealth's strong performance in the first half of 2025 reflects the profound ambition driving our transformation, building a global, future-ready healthcare ecosystem that is both technologically advanced and deeply human. By aligning innovation with national priorities and international partnerships, we are not only expanding access to care, but we are also reshaping how health is delivered, experienced, and sustained.' Shaista Asif, Group Chief Executive Officer at PureHealth, commented, 'We delivered solid growth in the first half of 2025 across both our Care and Cover verticals. Our entry into the Property & Casualty segment through Daman strengthens our ability to offer comprehensive, multi-line coverage. We continue to enhance our services through AI-powered solutions that make healthcare more intelligent and efficient. As we expand globally, our focus remains on synergies, transformation of the assets, and delivering better health outcomes within communities we operate.' The Care vertical was the largest contributor to revenue during the period, accounting for 72 per cent of the group's top-line at dh9.8 Billion in revenue, up 7 per cent year-on-year in h1 2025. This growth witnessed across several segments, including hospitals, diagnostics, and technology. Performance in UAE and UK was driven by a 13 per cent increase in outpatient volumes to 4.4 million visits, and a 7 per cent rise in inpatient volumes to 108,000 visits across the Hospitals vertical. In the UAE, this growth was supported by expanded service offerings, increased specialist capacity, and growing demand across SEHA and SSMC networks. In the UK, Circle Health saw increased patient volumes and further strengthened its position through the successful bolt on acquisition of Fairfield Independent Hospital in the Merseyside. The acquisition will expand inpatient capacity and available medical staff, which will ultimately support Circle Health's continued growth in high-demand regions. While Procurement revenue decreased 5 per cent year-on-year to Dh2.6 billion in H1 2025, Rafed has continued expansion of its supplier network. Its recent appointed role as the exclusive distributor for the Abu Dhabi government's Unified Purchasing Programme, has since strengthened its position as a central enabler within the Group's healthcare delivery model. PureLab recorded a 19 per cent year-on-year increase in total testing volume, reaching 16.9 million tests. This strong performance was largely fuelled by enhanced contributions from SEHA and the successful integration of the SSMC laboratory into the PureLab network. The Technology Services reported exceptional growth, with revenue increasing 170 per cent year-on-year to Dh367 million in H1-2025. This was driven by the continued expansion of PureCS, which deployed digital infrastructure and clinical technology solutions across the Group's entities. The Pura app surpassed 620,000 users during the period, while the Group's broader technology backbone is enabling predictive analytics, digital patient engagement, and AI-enhanced care delivery. The Cover vertical revenue increased 14 per cent year-on-year to Dh3.8 billion, supported by an 8 per cent rise in Gross Written Premiums (GWP) to Dh4.9 billion in H1-2025. Growth was further fuelled by new business, driven by expansion into underpenetrated segments and geographies. Membership increased 6 per cent year-on-year, reflecting the Group's compelling value proposition and strong customer retention. PureHealth's balance sheet remains strong, with a Net Debt to Ebitda ratio of 1.4x, providing the Group with ample flexibility to pursue future M&A opportunities and invest in strategic organic growth initiatives across its global healthcare platform. PureHealth repaid Dh1.85 billion in bank debt ahead of its 2027 maturity and currently has no bank debt.
Khaleej Times
7 hours ago
- Khaleej Times
Response Plus Holding reports Dh248 million revenue in H1
Response Plus Holding PJSC, the largest pre-hospital care and emergency medical services provider in the UAE and KSA, has achieved revenue of Dh248.06 million in the first six months of 2025, a growth of 18% compared to Dh209.88 million recorded in the same period last year. Announcing the company's interim financial results for the first half of 2025, RPM registered net profit of Dh20.32 million, while total assets touched Dh404.32 million, up from Dh387.44 million as of December 31, 2024, reflecting continued balance sheet strength and sustained investment momentum. The Earnings Per Share (EPS) for the period was Dh0.10. As part of its commitment to deliver shareholder value, the Board of Directors has approved an interim cash dividend distribution of Dh18 million to the shareholders. Dr Rohil Raghavan, Chief Executive Officer of Response Plus Holding, said: 'The first half of 2025 reflects our strategic agility and continued investment in excellence. From expanding into new geographies to launching the first-of-its-kind services in the region, we are driving impactful growth while prioritizing operational efficiencies. With a strong foundation and forward-looking initiatives, we are well-positioned to deliver greater value to our clients, partners, and shareholders.' RPM delivered strategic milestones during the first half of 2025, reinforcing its leadership in regional and global emergency medical care. The company expanded its aviation emergency operations to The Bahamas, demonstrating its capabilities to scale internationally while enhancing its disaster and air evacuation readiness. During the Hajj season, the company deployed 350 medical professionals and 125 ambulances in 18 clinics across nine stations of Saudi Arabia Railways to support millions of pilgrims visiting the Holy sites. RPM also signed a MoU with Falcon Aviation to operate the UAE's first air ambulance service, a landmark step in enhancing the country's emergency response infrastructure. RPM currently operates over 420 medical sites through key subsidiaries including Prometheus Medical, Occumed Clinic, Health Tech Training Centre, and Medical Manpower Supply. With operations spanning the UAE, KSA, Oman, India, the UK, Switzerland, and Norway, RPM remains firmly committed to redefining the future of pre-hospital emergency medical services.
Zawya
12 hours ago
- Zawya
PureHealth delivers strong H1 2025 results with AED 13.6bln in revenue and AED 1.03bln in net profit
Abu Dhabi – PureHealth Holding PJSC ('PureHealth' or 'the Group') (ADX Symbol: PUREHEALTH), the largest healthcare group in the Middle East, today announced its financial results for the six-month period ended 30 June 2025. The Group delivered a 9% year-on-year revenue increase to AED 13.6 billion in H1 2025, driven by broad-based growth across both its Healthcare (Care) and Insurance (Cover) verticals. EBITDA rose 8% year-on-year to AED 2.3 billion in H1-2025, while net profit reached AED 1.03 billion, up 2% year-on-year. As part of its continued evolution and transformation of acquired assets, PureHealth is streamlining its operating model built around two core verticals: Care and Cover. This structure brings together all Group businesses under each vertical, with 'Care' encompassing Hospitals, Procurement, Diagnostics, and Technology, while 'Cover' includes the Group's Insurance operations. The new model strengthens PureHealth's ability to deliver coordinated, value-driven services by aligning care delivery with insurance offerings to streamlining operations across all levels of the health ecosystem. Furthermore, as PureHealth is the only entity in the MENA region which has both healthcare and insurance services under one umbrella, this new streamlined approach gives more transparency and clarity for investors to understand the vertical performance of the group. H.E. Kamal Al Maazmi, Chairman of PureHealth, said: 'PureHealth's strong performance in the first half of 2025 reflects the profound ambition driving our transformation, building a global, future-ready healthcare ecosystem that is both technologically advanced and deeply human. By aligning innovation with national priorities and international partnerships, we are not only expanding access to care, but we are also reshaping how health is delivered, experienced, and sustained.' Shaista Asif, Group Chief Executive Officer at PureHealth, commented, 'We delivered solid growth in the first half of 2025 across both our Care and Cover verticals. Our entry into the Property & Casualty segment through Daman strengthens our ability to offer comprehensive, multi-line coverage. We continue to enhance our services through AI-powered solutions that make healthcare more intelligent and efficient. As we expand globally, our focus remains on synergies, transformation of the assets, and delivering better health outcomes within communities we operate.' Financial & Operational Highlights Across Healthcare (Care) and Insurance (Cover) Verticals: The Care Vertical was the largest contributor to revenue during the period, accounting for 72% of the Group's top-line at AED 9.8 billion in revenue, up 7% year-on-year in H1 2025. This growth witnessed across several segments, including Hospitals, Diagnostics, and Technology. Performance in UAE and UK was driven by a 13% increase in outpatient volumes to 4.4 million visits, and a 7% rise in inpatient volumes to 108,000 visits across the Hospitals vertical. In the UAE, this growth was supported by expanded service offerings, increased specialist capacity, and growing demand across SEHA and SSMC networks. In the UK, Circle Health saw increased patient volumes and further strengthened its position through the successful bolt on acquisition of Fairfield Independent Hospital in the Merseyside. The acquisition will expand inpatient capacity and available medical staff, which will ultimately support Circle Health's continued growth in high-demand regions. While Procurement revenue decreased 5% year-on-year to AED 2.6 billion in H1 2025, Rafed has continued expansion of its supplier network. Its recent appointed role as the exclusive distributor for the Abu Dhabi government's Unified Purchasing Programme, has since strengthened its position as a central enabler within the Group's healthcare delivery model. PureLab recorded a 19% year-on-year increase in total testing volume, reaching 16.9 million tests. This strong performance was largely fuelled by enhanced contributions from SEHA and the successful integration of the SSMC laboratory into the PureLab network. The Technology Services reported exceptional growth, with revenue increasing 170% year-on-year to AED 367 million in H1-2025. This was driven by the continued expansion of PureCS, which deployed digital infrastructure and clinical technology solutions across the Group's entities. The Pura app surpassed 620,000 users during the period, while the Group's broader technology backbone is enabling predictive analytics, digital patient engagement, and AI-enhanced care delivery. The Cover vertical revenue increased 14% year-on-year to AED 3.8 billion, supported by an 8% rise in Gross Written Premiums (GWP) to AED 4.9 billion in H1-2025. Growth was further fuelled by new business, driven by expansion into underpenetrated segments and geographies. Membership increased 6% year-on-year, reflecting the Group's compelling value proposition and strong customer retention. PureHealth's balance sheet remains strong, with a Net Debt to EBITDA ratio of 1.4x, providing the Group with ample flexibility to pursue future M&A opportunities and invest in strategic organic growth initiatives across its global healthcare platform. PureHealth repaid AED 1.85 billion in bank debt ahead of its 2027 maturity and currently has no bank debt. Strategic Developments PureHealth acquired Hellenic Healthcare Group (HHG), the largest private healthcare provider in Greece and Cyprus, strengthening its presence in Europe and expanding its specialised care footprint. Closing of the transaction is subject to EU regulatory approvals. Circle Health Group completed the acquisition of Fairfield Independent Hospital in Merseyside, adding inpatient capacity and expanding Circle's footprint in high-demand regions across the UK. Daman has received approvals and licensing to enter the Property & Casualty insurance segment, marking its evolution into a comprehensive, multi-line insurer. It also launched new insurance offerings targeting underpenetrated segments and continued scaling digital claims and onboarding systems. SEHA, through Sheikh Khalifa Medical City (SKMC), signed a strategic partnership with Cincinnati Children's Hospital, one of the top ranked US children's hospital, to advance paediatric clinical services, research, and training in Abu Dhabi. Rafed was appointed as the exclusive distributor for the Unified Purchasing Programme under the Abu Dhabi government mandate, reinforcing its central position in the national procurement ecosystem. OneHealth introduced TurnKey Solutions and Home Dialysis Project, supporting PureHealth's expansion toward home-based care and specialised treatment pathways. Outlook PureHealth is advancing its organic growth strategy through targeted investments in high-margin, complex medical capabilities, the development of clinical centres of excellence, and operational efficiency enhancements enabled by digital health and AI. In parallel, PureHealth continues to expand its international footprint through focused M&A, including the acquisition of Hellenic Healthcare Group (HHG) in Greece and Cyprus. The Group's expansion strategy is supported by a balanced capital allocation framework, combining reinvestment in core strengths with a commitment to shareholder returns. -Ends- About PureHealth: PureHealth is the largest healthcare group in the Middle East with an ecosystem that challenges lifespans and reimagines health spans. With 110+ hospitals, 316+ clinics, multiple diagnostic centres, health insurance solutions, pharmacies, health tech, procurement, investments and more, its groundbreaking innovations are at the forefront of healthcare as the company is on a mission to unlock time for humankind. By advancing the Science of Longevity, PureHealth is introducing the healthcare of the future from the United Arab Emirates to the rest of the world. PureHealth's network comprises: SEHA – One of the largest healthcare networks of hospitals and clinics in the UAE SEHA CLINICS - Delivering comprehensive community-based healthcare services Daman (The National Insurance Company) – The UAE's leading health insurer The Medical Office – Overseeing Sheikh Khalifa Hospitals and healthcare facilities established under the initiatives of H.H. The President of the UAE Rafed – The UAE's largest healthcare Group Purchasing Organisation PureLab – Managing and operating the largest network of laboratories in the region One Health – A network that provides end-to-end medical solutions to a base of over 300 healthcare service providers The Life Corner – Abu Dhabi's first holistic pharmacy, serving the health and wellness establishment Ardent Health Services – The fourth largest privately held acute care hospital operator in the US Circle Health Group – The largest independent operators of hospitals in the UK Hellenic Healthcare Group (HHG) - the largest private healthcare provider in Greece and Cyprus PureCS - A leading cloud and technology services provider, specialising in IT management and consulting solutions, cybersecurity, cloud services and AI information systems Sheikh Shakhbout Medical City (SSMC) – The UAE's largest healthcare complex, delivering integrated complex care To learn more, please visit
